Manuel Kunst

Liability Of The Applicant For A Precautionary Measure Is To Be Determined Case By Case And Based On The Applied National Legislation – Two Recent ECJ Decisions

First Instance Declares German CureVac Patent On MRNA Vaccine Against Covid-19 Invalid

Orphan Drugs - Market Exclusivity Outside Patent Protection

Moderna Patent On MRNA Vaccine Against COVID-19 Revoked

Unitary Patent - Number Of Unitary Patent Applications In Europe

Conditions For An Action For Revocation Even After Patent Expiry - Protection Of Individual Rights And Interests

Plausibility And Inventive Step – Two Critical Hurdles For Patenting

EPO Board Of Appeal Upholds Patent For A Better-tasting Barley Variety